Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)

China flag China · Delayed Price · Currency is CNY
24.68
+0.45 (1.86%)
Mar 6, 2026, 4:00 PM EST
33.69%
Market Cap 4.63B
Revenue (ttm) 1.47B
Net Income (ttm) 162.56M
Shares Out 190.18M
EPS (ttm) 0.85
PE Ratio 28.64
Forward PE n/a
Dividend 0.50 (2.03%)
Ex-Dividend Date Nov 28, 2025
Volume 1,323,170
Average Volume 1,501,483
Open 24.28
Previous Close 24.23
Day's Range 24.11 - 24.74
52-Week Range 17.62 - 41.47
Beta 0.11
RSI 33.64
Earnings Date Apr 28, 2026

About SHE:003020

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally. The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA. It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlor... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 1,456
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 003020
Full Company Profile

Financial Performance

In 2024, SHE:003020's revenue was 1.52 billion, a decrease of -20.11% compared to the previous year's 1.90 billion. Earnings were 160.60 million, a decrease of -29.15%.

Financial Statements

News

There is no news available yet.